1887

Abstract

SUMMARY

Three methods of pelleting, ultracentrifugation (95000 g for 60 min), precipitation with polyethylene glycol 6000 (5% v/v), and with ammonium sulphate (38% w/v), were used to concentrate human cytomegalovirus (CMV) from tissue culture fluids. Maximum recovery of infectious virus particles was obtained with the polyethylene glycol (PEG) method. The precipitating activity of PEG 6000 and PEG 20000 was then compared at different concentrations. The best results were obtained with PEG 6000 at a final concentration of 5% (v/v). Changes in pH or salt concentration, treatment of the concentrates with Pronase and long periods of time at 4 °C significantly reduced the number of biologically active CMV particles recovered by PEG precipitation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-42-1-193
1979-01-01
2022-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/42/1/JV0420010193.html?itemId=/content/journal/jgv/10.1099/0022-1317-42-1-193&mimeType=html&fmt=ahah

References

  1. Adams A. 1973; Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol. Journal of General Virology 20:391–394
    [Google Scholar]
  2. Bronson D. L., Elliott A. Y., Ritzi D. 1975; Concentration of Rous sarcoma virus from tissue culture fluids with polyethylene glycol. Applied Microbiology 30:464–471
    [Google Scholar]
  3. Elek S. D., Stern H. 1974; Development of vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet i:1–5
    [Google Scholar]
  4. Fiala M., Honess R. W., Heiner D. C. Jun, Heine J. W., Murnane J., Wallace R., Guze L. B. 1976; Cytomegalovirus proteins I. Polypeptides of virions and dense bodies. Journal of Virology 19:243–254
    [Google Scholar]
  5. Forghani B., Schmidt N. J., Lennette E. H. 1976; Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems. Infection and Immunity 14:1184–1190
    [Google Scholar]
  6. Hanshaw J. B. 1974; A cytomegalovirus vaccine?. American Journal of Diseases of Children 128:141–142
    [Google Scholar]
  7. Huang E. S., Chen S. T., Pagano J. S. 1973; Human cytomegalovirus I. Purification and characterization of viral DNA. Journal of Virology 12:1473–1481
    [Google Scholar]
  8. Iverius P. H., Laurent T. C. 1967; Precipitation of some plasma proteins by the addition of dextrin or polyethylene glycol. Biochimica et Biophysica Acta 133:371–373
    [Google Scholar]
  9. Kilpatrick B. A., Huang E. S., Pagano J. S. 1976; Analysis of cytomegalovirus genomes with restriction endonucleases Hind III and EcoR-1. Journal of Virology 18:1095–1105
    [Google Scholar]
  10. Leberman R. 1966; The isolation of plant viruses by means of ‘simple’ coacervates. Virology 30:341–347
    [Google Scholar]
  11. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
  12. Mukojima T., Gunven P. 1973; Circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt’s lymphoma. Journal of the National Cancer Institute 15:1319–1321
    [Google Scholar]
  13. Robinson W. S., Duesbero P. H. 1968; The chemistry of the RNA tumor viruses. In Molecular Basis of Virology pp 306–331 Edited by Fraenkel-Conrat H. New York: Reinhold;
    [Google Scholar]
  14. Schmidt N. J., Dennis J., Lennette E. H. 1976; Plaque reduction neutralization test for human cytomegalovirus leased upon enhanced uptake of neutral red by virus-infected cells. Journal of Clinical Microbiology 4:61–66
    [Google Scholar]
  15. Stinski M. F. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. Journal of Virology 19:594–609
    [Google Scholar]
  16. Talbot P., Almeida J. D. 1977; Human cytomegalovirus: purification of enveloped virions and dense bodies. Journal of General Virology 36:345–349
    [Google Scholar]
  17. Weliky N., Leaman D. H. Jun, Kallman B. J. 1975; Purification of soluble complement fixing antigens from 2 Burkitt’s lymphoma cell lines: conditions affecting the stability and recovery of antigens and antibodies. Immunology 29:779–790
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-42-1-193
Loading
/content/journal/jgv/10.1099/0022-1317-42-1-193
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error